BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August

Day

• 1
• 2
• 3
• 4
• 7
• 8
• 9
• 10
• 11
• 14
• 15
• 16
• 17
• 18
• 21
• 22
• 23
• 24
• 25
• 28
• 29
• 30
• 31

• 

  Government

  New CDER Head Tidmarsh Will Sub In At Biologics Group After Prasad’s Exit

  George Tidmarsh has only been at the Center for Drug Evaluation and Research for nine days, but will now add supervision of a second FDA division to his portfolio after Vinay Prasad’s sudden departure.

  July 30, 2025

   · 

  1 min read

   · 

  Dan Samorodnitsky
• Press Releases

  Onco-Innovations Announces Private Placement

  July 30, 2025

   · 

  4 min read
• Press Releases

  GRAIL to Announce Second Quarter 2025 Financial Results

  July 30, 2025

   · 

  1 min read
• Press Releases

  Kedrion Biopharma Receives Orphan Drug Designation for COAGADEX® for Acquired Factor X Deficiency (aFXD) and Starts Clinical Trial to Evaluate Efficacy and Safety

  July 30, 2025

   · 

  4 min read
• Press Releases

  Harbour BioMed to Present Phase II Data of HBM4003 and Tislelizumab Combination in MSS Metastatic Colorectal Cancer at ESMO 2025

  July 30, 2025

   · 

  3 min read
• Press Releases

  Larimar Therapeutics Announces Pricing of Underwritten Public Offering

  July 30, 2025

   · 

  4 min read
• Press Releases

  Telix H1 2025 Results: Investor Webcast Notification

  July 30, 2025

   · 

  5 min read
• Press Releases

  Penumbra, Inc. Reports Second Quarter 2025 Financial Results

  July 30, 2025

   · 

  19 min read
• Press Releases

  Inventiva Reports Preliminary 2025 First-Half Financial Information¹

  July 30, 2025

   · 

  12 min read
• Press Releases

  Larimar Therapeutics Announces Proposed Underwritten Public Offering

  July 30, 2025

   · 

  4 min read